Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/19872
Título
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain
Autor(es)
Mazagatos, Clara ISCIII | Mendioroz, Jacobo | Rumayor, Mercedes Belén | Gallardo García, Virtudes | Álvarez Río, Virginia | Cebollada Gracia, Ana Delia | Batalla Rebollo, Noa | Barranco Boada, María Isabel | Pérez-Martínez, Olaia | Lameiras Azevedo, Ana Sofía | López González-Coviella, Nieves | Castrillejo, Daniel | Fernández Ibáñez, Ana | Giménez Duran, Jaume | Ramírez Córcoles, Cristina | Ramos Marín, Violeta | Larrauri, Amparo ISCIII | Monge Corella, Susana ISCIII | SARI Sentinel Surveillance RSV Study Group
Fecha de publicación
2024-05
Cita
Influenza Other Respir Viruses. 2024 May;18(5):e13294.
Idioma
Inglés
Tipo de documento
research article
Resumen
Background: Data from the sentinel surveillance system of severe acute respiratory infections in Spain were used to estimate the impact of administration of nirsevimab to children born from 1 April 2023 onwards. Methods: Estimated RSV hospitalisations in < 1-year-olds during weeks 40, 2023, to 8, 2024, were compared to the number that would be expected after accounting for the background change in RSV circulation in the 2023/24 season, compared to 2022/23. Results: We estimated 9364-9875 RSV hospitalisations less than expected, corresponding to a 74%-75% reduction.
Palabras clave
MESH
Respiratory Syncytial Virus Infections | Hospitalization | Antiviral Agents | Humans | Spain | Infant | Incidence | Female | Male | Respiratory Syncytial Virus, Human | Sentinel Surveillance | Infant, Newborn | Antibodies, Monoclonal, Humanized
Versión en línea
DOI
Aparece en las colecciones
Ficheros en el ítem
- Nombre:
- EstimatedImpactNirsevimabVRS_2 ...
- Tamaño:
- 1.818Mb
- Formato:
- Descripción:
- Articulo
- Nombre:
- Supplement_EstimatedImpactNirs ...
- Tamaño:
- 984.5Kb
- Formato:
- Descripción:
- supplementary material